BioTesch Holding ApS
CVR 39660350 · Private limited company (ApS) · Active · Low risk
BioTesch Holding ApS is a Private limited company (ApS), founded on , based in Holte. The company is registered in the industry anden finansiel formidling i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published. The latest annual report (30 Jun 2026) shows equity of DKK 3.3m and a net result of DKK -240k. CEO: Anker Gunvald Lundemose.
Bankruptcy risk for BioTesch Holding ApS
0.0 × the average (1.41%) · higher risk than 18% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39660350
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- c/o Anker Lundemose, Tesch Alle 2
2840 Holte - Municipality
- Rudersdal
- Industry
- Anden finansiel formidling i.a.n. (649990)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 510k
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 99.4% |
| Current ratio | 4,164% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | – | DKK 0 | DKK 0 |
| Gross profit | DKK -47k | DKK -44k | DKK -51k |
| Net profit | DKK -240k | DKK -1.3m | DKK -48k |
| Equity | DKK 3.3m | DKK 3.6m | DKK 4.8m |
| Total assets | DKK 3.3m | DKK 3.6m | DKK 4.8m |
| Cash | DKK 788k | DKK 76k | – |
| Short-term debt | DKK 19k | DKK 22k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Grant Thornton, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2025 – 30 Jun 2026 | 65 | ||
| 1 Jul 2024 – 30 Jun 2025 | 84 | ||
| 1 Jul 2023 – 30 Jun 2024 | 68 | ||
| 1 Jul 2022 – 30 Jun 2023 | 74 | ||
| 1 Jul 2021 – 30 Jun 2022 | 63 | ||
| 1 Jul 2020 – 30 Jun 2021 | 64 | ||
| 1 Jul 2019 – 30 Jun 2020 | 38 | ||
| 19 Jun 2018 – 30 Jun 2019 | 71 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Anker Gunvald Lundemose | Current | |
| Owner (67%) | Anker Gunvald Lundemose | Current | |
| Owner (15%) | SWAL APS | Current | |
| Founder | Anker Gunvald Lundemose | Current |
The CEOs' other companies
Anker Gunvald Lundemose – 15 other companies, of which 1 bankrupt
- AZIGN BIOSCIENCE A/S Bankrupt 7 Nov 2018
- 3B INVEST ApS Fusioneret
- ADENIUM BIOTECH ApS Opløst
- Antag Therapeutics ApS Active
- BIOTESCH ADVICE & CONSULTANCY ApS Opløst
- Commit Biologics ApS Active
- FTL AF 21/3-2001 A/S Opløst
- ONCOTAC PHARMACEUTICALS ApS Opløst
- PROLIFERATOR ApS Opløst
- RICC A/S Active
- ROS Therapeutics ApS Opløst
- SANIONA A/S Active
- Servier Symphogen A/S Active
- Synuca Therapeutics ApS Active
- TOPOTARGET A/S Fusioneret
Address history (0 moves)
| c/o Anker Lundemose, Tesch Alle 2, 2840 Holte |
Other companies at the same address
Similar companies in Rudersdal
- ANNI BACKHAUSEN ApS Nærum
- STEEN MICHAEL ApS Skodsborg
- JAN ROLAND JACOBSEN ApS Holte
- PETER JOHNSEN ApS Vedbæk
- HAMRE FINANS ApS Vedbæk
- OLE NYMARK JENSEN - POUL HANSEN TRADING ApS Hørsholm
- CAMILLA OG LARS THØGERSEN ApS Birkerød
- KNUD RIEDEL A/S Skodsborg
- ANRAMA ApS Holte
- BOGTIK ApS Nærum
- ANNELISE STABERG ApS Holte
- KIM CHRISTENSEN ApS Skodsborg
Questions and answers about BioTesch Holding ApS
Has BioTesch Holding ApS gone bankrupt?
No, BioTesch Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BioTesch Holding ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of BioTesch Holding ApS?
Anker Gunvald Lundemose is the CEO of BioTesch Holding ApS.
Who is the auditor of BioTesch Holding ApS?
BioTesch Holding ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was BioTesch Holding ApS founded?
BioTesch Holding ApS was founded on 19 June 2018.
What is the equity of BioTesch Holding ApS?
Equity was DKK 3.3m according to the annual report for the period ending 30 June 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.